Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | EDARAVONE (D01552) | [1] Edaravone Edaravone | [1] Edaravone
Edaravone
(D01552) 💬 | - | - | [3] 2 2, 6, 22 💬 |
2 | Edaravone (Radicava®/Radicava ORS®) (D01552) | [1] Edaravone Edaravone | [1] Edaravone
Edaravone
(D01552) 💬 | - | - | [1] 2 2 💬 |
3 | Scopolamine, atropine, edaravone and dexmedetomidine (D01552) | [4] Atropine Atropine,Dexmedetomidine, Edaravone, Scopolamine | [4] Atropine
Atropine
,Scopolamine , Dexmedetomidine , Edaravone (D01552) 💬 | [8] ADRA2A ADRA2A,ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬 |